Skip to main content
logo
Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
34.38
+0.21 (0.61%)
At close: Aug 26, 2026, 4:00 PM EDT
34.40
+0.02 (0.06%)
After-hours: Aug 26, 2026, 7:53 PM EDT

Viking Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4,0113,9774,4841,862721360
Market Cap Growth
37.18%-11.32%140.89%158.23%100.31%-12.38%
Enterprise Value
3,5133,2633,5551,487567144
Last Close Price
34.3835.1840.2418.619.404.60

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
9.826.225.095.344.961.78
P/TBV Ratio
9.826.225.095.344.961.78

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.0100.000.000.010
Net Debt / Equity Ratio
-1.22-1.10-1.02-1.04-1.06-1.00
Quick Ratio
4.589.2132.9318.927.0923.02
Current Ratio
4.729.3333.0919.197.6123.98
Return on Equity (ROE)
-88.85%-47.34%-17.90%-34.79%-39.67%-24.65%
Return on Assets (ROA)
-51.86%-30.28%-14.77%-23.47%-23.19%-14.90%
Return on Capital Employed (ROCE)
-135.80%-61.50%-17.10%-28.90%-48.00%-27.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-13.33%-9.04%-2.45%-4.61%-9.55%-15.28%
Buyback Yield / Dilution
-2.64%-3.33%-15.57%-22.79%0.47%-6.34%
SEC Filings: 10-K · 10-Q